Rhythm Pharmaceuticals Inc.

NASDAQ:RYTM  
22.54
+1.36 (+6.42%)
Earnings Announcements

Rhythm Pharmaceuticals Reports Q1 EPS Of $0.90

Published: 05/03/2021 12:34 GMT
Rhythm Pharmaceuticals Inc. (RYTM) - Rhythm Pharmaceuticals Reports First Quarter 2021 Financial Results.
Q1 Earnings per Share $0.90.
Revenue is expected to be $0.8 Million
Adjusted EPS is expected to be -$0.69

Next Quarter Revenue Guidance is expected to be $1.61 Million
Next Quarter EPS Guidance is expected to be -$0.74

More details on our Analysts Page.